Stig Lenhoff (Former)
21 – 30 of 53
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Being a haematopoietic stem cell donor for a sick sibling: Adult donors' experiences prior to donation.
(
- Contribution to journal › Article
-
Mark
Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial.
(
- Contribution to journal › Article
-
Mark
Outcome and risk factor analysis of molecular subgroups in cytogenetically normal AML treated by allogeneic transplantation.
(
- Contribution to journal › Article
-
Mark
Young woman with mild bone marrow dysplasia, GATA2 and ASXL1 mutation treated with allogeneic hematopoietic stem cell transplantation.
(
- Contribution to journal › Article
-
Mark
Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.
(
- Contribution to journal › Article
-
Mark
Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
(
- Contribution to journal › Article
- 2014
-
Mark
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide
(
- Contribution to journal › Article
-
Mark
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
(
- Contribution to journal › Article
-
Mark
Having a sibling as donor: Patients' experiences immediately before allogeneic hematopoietic stem cell transplantation.
(
- Contribution to journal › Article
- 2013
-
Mark
Potential adult sibling stem cell donors' perceptions and opinions regarding an information and care model.
(
- Contribution to journal › Article